1st Quarter - Termination

HEALTH AND MEDICINE COUNSEL for NEPHURE

Firm
Client
Income
$10,000
Expenses
—
Terminated
Feb 1, 2024

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY24 L-HHS Approps FY24 MilCon-VA Approps FY24 Defense Approps

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
KIRA FLAHERTY Legislative Consultant
PHILIP GOGLAS Legislative Consultant

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Health Issues HCR

Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
KIRA FLAHERTY Legislative Consultant
PHILIP GOGLAS Legislative Consultant

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 652 (118th), H.R. 830 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.